Semisolid systems containing propolis fo
β
Marcos L. Bruschi; David S. Jones; Heitor Panzeri; Maria P.D. GremiΓ£o; Osvaldo d
π
Article
π
2007
π
John Wiley and Sons
π
English
β 214 KB
Formulations containing poloxamer 407 (P407), carbopol 934P (C934P), and propolis extract (PE) were designed for the treatment of periodontal disease. Gelation temperature, in vitro drug release, rheology, hardness, compressibility, adhesiveness, mucoadhesion, and syringeability of formulations were